期刊文献+

新辅助化疗在晚期卵巢上皮性癌中的应用现状 被引量:9

下载PDF
导出
摘要 卵巢上皮性癌是死亡率最高的妇科恶性肿瘤。临床常用的治疗方案是理想的初次肿瘤细胞减灭术及术后辅以铂类+紫杉醇为基础的系统化疗。对晚期不能切除的卵巢癌,新辅助化疗能降低肿瘤负荷,提高手术切除的彻底性,是一种新的治疗策略。本文就新辅助化疗在卵巢癌治疗中的概念、目的、病例选择标准、术前选择新辅助化疗的评估方法、化疗方案、疗程、给药途径,疗效评价及临床价值等进行综述。
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2011年第4期264-268,共5页 Journal of Practical Obstetrics and Gynecology
基金 四川省重点医学学科建设项目(项目编号:2007407)
  • 相关文献

参考文献26

  • 1Fotopoulou C, Savvatis K. Primary Radical Surgery in Elderly Patients With Epithelial Ovarian Cancer Analysis of Surgical Outcome and Long-Term Survival[J]. Int J Gyneeol Cancer ,2010,20( 1 ) : 34 -40.
  • 2Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gyneco- logical Cancer[ J]. Int J Gynaecol Obstet,2006,95 : 161 - 192.
  • 3Traeey EA, Roder DM. Reasons for Improved Survival From Ovarian Cancer in New South Wales, Australia, Between 1980 and 2003 Implications for Cancer Control [ J]. Int J Gynecol Cancer, 2009,19 (4) :591 -599.
  • 4Vergote I, De Wever I, Tjalma W, et al. Interval debulking surgery: an alternative for primary surgical debulking[ J ]. Semin Surg Oncol, 2000,19 ( 1 ) :49 - 53.
  • 5Deo C, Goyal H, Shukla NK, et al. Neoadjuvant chemotherapy fol- lowed by surgical cytoreduction in advanced epithelial ovarian cancer [ J]. Indian J Cancer,2006,43 (3) : 117 - 121.
  • 6Hou JY, Kelly MG, Yu H, et al. Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease [ J ]. Gynecologic Oncology, 2007,105 (1) :211 -217.
  • 7Qayyum A, Coakley FV, Westphalen AC, et al. Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed prima- ry epithelial ovarian cancer. [ J ] Gynecol Oncol , 2005,96 ( 2 ) : 301 - 306.
  • 8Salani R, Axtell A, Gerardi M, et al. Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer[ J]. Gynecol Oncol ,2008,108 (2) : 271 - 275.
  • 9Ruiz-Hemandez G, Delgado-Bohon RC, Fernandez-Perez C, et al. Meta-analysis of the diagnostic efficacy of FDG-PET in paients with suspected ovarian cancer recurrence [ J]. Rev Esp Med Nud,2005, 24(3) :161 -173.
  • 10Bristow RE, Giuntofi RL 2nd, Pannu HK, et al. Combined PETCT for detecting recurrent ovarian cancer limited to retropefitoneal lymph nodes [ J ]Ⅱ. Gynecol Oncol,2005,99 ( 2 ) : 294 - 300.

同被引文献77

  • 1孙秀华,王瑞斐,徐洋.新辅助治疗晚期卵巢上皮性癌30例临床分析[J].中国肿瘤临床与康复,2006,13(3):239-240. 被引量:2
  • 2Vergote I, De Wever I, Tjalma W, et al. Interval debulking surgery: an alternative for primary surgical debulking? [J]. Semin Surg Oncol, 2000,19:49-53.
  • 3Loizzi V, Cormio G, Resta L, et al. Neoadjuvant chemotherapy in advanced ovariancancer: a case-control study [J]. Int J Gynecol Cancer, 2005, 15,217-223.
  • 4Neijt JP, ten Bokkel Huinink WW, van der Burg ME, et al. Randomized trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5 ) in advanced ovarian carcinoma [J]. Lancet, 1984,2:594-600.
  • 5Omura GA, Bundy BN, Berek JS, et al. Mortel R. Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: A gynecologic oncology group study [J]. J Clin Onco1,1989,7:457-465.
  • 6Steed H, Murphy J. A retrospective analysis of neoadjuvant platinum-based chemotherapy versus up-front surgery in advanced ovarian dancer[J]. Int J Gynecol Cancer,2006, 16 (Suppl 1): 47-53.
  • 7Everett EN, French AE, Stone RL, et al. Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer[J]. Am J Obstet Gynecol, 2006,195: 568-576.
  • 8Schwartz PE. What is the role of neoadjuvant chemotherapy in the management of ovarian cancer? [J]. Oncology, 2008, 22(10) : 1118-1126.
  • 9Loizzi V, Cormio G, Resta L, et al. Neoadjuvant chemotherapy in advanced ovariancancer: a case-control study[J]. Int J Gynecol Cancer, 2005, 15:217-223.
  • 10Martin P, Sven M, Olaf O,et al. Neoadjuvant chemotherapy with carboplatin and docetaxel in advanced ovarian caneer-a prospective multicenter phase Ⅱ trial (PRIMOVAR) [J]. Oncol Rep, 2009,22(3) :605-613.

引证文献9

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部